Water → 6-[2,3-Dihydro-2-oxo-1H-benzimidazol-1-ylmethyl]-1,2,3,4-tetrahydro-3-methyl-1-(isobutyl)-2,4-dioxo-thieno[2,3-d]pyrimidine-5-carboxylic acid, methyl ester
반응식
Cl[C:2]1[N:3]=[C:4](C)[N:5]([CH2:8][C:9]2[S:24][C:12]3[N:13]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:14](=[O:19])[N:15]([CH3:18])[C:16](=[O:17])[C:11]=3[C:10]=2[C:25](N2C[C@H](O)CO2)=[O:26])[C:6]=1Cl.ClC1N[C:37]2C=C[CH:41]=[CH:40][C:38]=2N=1.[C:44](=O)([O-])[O-:45].[K+].[K+].CN(C=O)C.[OH2:55]>C(OCC)(=O)C>[O:55]=[C:4]1[N:5]([CH2:8][C:9]2[S:24][C:12]3[N:13]([CH2:20][CH:21]([CH3:23])[CH3:22])[C:14](=[O:19])[N:15]([CH3:18])[C:16](=[O:17])[C:11]=3[C:10]=2[C:25]([O:45][CH3:44])=[O:26])[C:6]2[CH:37]=[CH:38][CH:40]=[CH:41][C:2]=2[NH:3]1참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
The product of example 3 part b) (0.5 g, 1.28 mmol), 2-chlorobenzimidazole (0.21 g, 1.37 mmol), potassium carbonate (0.36 g, 2.6 mmol) and DMF (10 ml) were stirred for 1.5 h. Ethyl acetate and water were added to the reaction mixture. The two phases were separated, the organic layer was dried (MgSO4) and then concentrated in vacuo. The residue was purified by biotage eluting with dichloromethane to give the sub-title compund as a pale yellow solid, 0.36 g (61%). δ 1HD6DMSO 0.83 and 0.91 (6H, d), 2.1-2.22 (1H,m), 3.38 (3H,s), 3.67 (2H,d), 4.1 (3H,s), 5.58 (2H,s), 7.26-7.38 (2H,m), 7.41-7.48 (1H,m) and 7.7-7.8 (1H,m).
후처리
- customThe two phases were separated
- dry with materialthe organic layer was dried (MgSO4)
- concentrationconcentrated in vacuo
- customThe residue was purified by biotage
- washeluting with dichloromethane
- customto give the sub-title compund as a pale yellow solid, 0.36 g (61%)
출처 및 근거
- ORD 기록
- ord-56eb70ac79244e5a9cba5c5fb95804f0
- 출처 데이터셋
- uspto-grants-2008_06
- 특허 번호
- US07384950B2
반응 노트
불러오는 중…